SIGA Technologies to Host Business Update Call on May 4th, 2023 Following Release of First Quarter 2023 Financial Results
27 avr. 2023 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2022
02 mars 2023 16h05 HE
|
SIGA Technologies Inc.
- Approximately $71 Million of International Product Sales in 2022 - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc....
SIGA Technologies to Host Business Update Call on March 2nd, 2023 Following Release of Fourth Quarter and Full Year 2022 Financial Results
23 févr. 2023 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA Technologies Announces Planned Retirement of CEO Phil Gomez in 2023
17 janv. 2023 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Phil...
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2022
03 nov. 2022 16h05 HE
|
SIGA Technologies Inc.
- Approximately $61 Million of International Sales in the Third Quarter – - Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies,...
SIGA Technologies to Host Business Update Call on November 3rd, 2022 Following Release of Third Quarter 2022 Financial Results
27 oct. 2022 16h15 HE
|
SIGA Technologies Inc.
NEW YORK, Oct. 27, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox
12 oct. 2022 16h05 HE
|
SIGA Technologies Inc.
Trials are currently underway in the United States, United Kingdom and Democratic Republic of CongoPending positive results from clinical trials, SIGA plans to file with U.S. regulators for regulatory...
SIGA Technologies Announces New Contract Awarded by U.S. Department of Defense for the Procurement of up to $10.7 Million of Oral TPOXX®
29 sept. 2022 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the...
SIGA Announces Approximately $16 Million of International Procurement Orders Received in August and Early September for Oral TPOXX® (Tecovirimat)
26 sept. 2022 10h07 HE
|
SIGA Technologies Inc.
- Order for Approximately $10 Million Funded by the European Commission – - Orders for Approximately $6 Million Received from Two Countries in the Asia Pacific Region - NEW YORK, Sept. 26,...
SIGA Announces BARDA Exercise of Procurement Options Valued at Approximately $26 Million for IV TPOXX®
09 août 2022 07h30 HE
|
SIGA Technologies Inc.
- IV TPOXX is an Important Option for Those Unable to Swallow – - Option to Fund Post-Marketing Field Study for IV TPOXX also Exercised – NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SIGA...